ARGX vs CHE
argenx SE vs Chemed Corp. — AI-powered side-by-side comparison
| Metric | ARGX | CHE |
|---|
| AI Score |
66
|
64
|
| Price |
$876.01
|
$541.60
|
| P/E Ratio |
31.23×
|
26.96×
|
| ROE |
17.6%
|
27.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
89.9%
|
30.4%
|
| Debt / Equity |
0.01×
|
0.35×
|
| Dividend Yield |
0.0%
|
0.4%
|
| RSI (14) |
47.9
|
53.7
|
| Beta |
-0.022
|
0.511
|
| Expected Upside |
+1.8%
|
+0.2%
|
AI Committee View
Current Innellis committee reasoning for ARGX versus CHE.
ARGX leads by 2 points.
ARGX scores 66/100 (Buy) versus CHE at 64/100 (Buy).
ARGX Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 22.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 71.3% YoY -- genuine top-line momentum — Growth
- EPS growing 95.7% YoY — Growth
Bear Case
- Price-to-book of 6.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
CHE Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock. The main limiting factor is p/e of 26.2 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 29.4% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 26.2 is moderate-to-rich — Value
- Price-to-book of 6.2x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical